CTRC Upcoming Events

  • Home-Brewed Drugs and the Drug Development Process
    Date: July 11, 2017
    Times: 4:00 PM - 5:00 PM
    Description: Andrei Gudkov, PhD, DSc, "NAMPT Inhibitor OT-82 targeting energy metabolism in hematologic malignancies" Organized by the UB Clinical and Translational Science Institute Drug Development Core, this series presents: - Case studies in drug discovery and pre-clinical development - Opportunities to become familiar with GLP and pre-clinical drug development programs - Regulatory compliance leading to IND application - Strategies for translation to Phase I study design
  • CTSI Community Engagement Core Outreach Program
    Date: July 26, 2017
    Times: 6:00 PM - 7:00 PM
    Description: UB on the Green Experience UB Night
  • Home-Brewed Drugs and the Drug Development Process
    Date: August 01, 2017
    Times: 4:00 PM - 5:00 PM
    Description: Katerina Gurova, MD, PhD, and Joseph Skitzki, MD, "Curaxins: Novel epigenetic anticancer drug" Organized by the UB Clinical and Translational Science Institute Drug Development Core, this series presents: - Case studies in drug discovery and pre-clinical development - Opportunities to become familiar with GLP and pre-clinical drug development programs - Regulatory compliance leading to IND application - Strategies for translation to Phase I study design
  • CTSI Community Engagement Core Outreach Program
    Date: August 26, 2017
    Times: 11:00 AM - 7:00 PM
    Description: The Elmwood Avenue Festival of the Arts mission is to foster growth in and awareness of Western New York’s artistic and cultural treasures and improve the fabric of our unique urban environment.
  • Home-Brewed Drugs and the Drug Development Process
    Date: September 05, 2017
    Times: 4:00 PM - 5:00 PM
    Description: Lyudmila Burdelya, PhD, and Vadim Krivokrysenko, PhD, "Entolimod as a dual use oncology biodefense drug" Organized by the UB Clinical and Translational Science Institute Drug Development Core, this series presents: - Case studies in drug discovery and pre-clinical development - Opportunities to become familiar with GLP and pre-clinical drug development programs - Regulatory compliance leading to IND application - Strategies for translation to Phase I study design
  • Home-Brewed Drugs and the Drug Development Process
    Date: October 03, 2017
    Times: 4:00 PM - 5:00 PM
    Description: Robert Fenstermaker, MD, "Anti-GBM vaccine" Organized by the UB Clinical and Translational Science Institute Drug Development Core, this series presents: - Case studies in drug discovery and pre-clinical development - Opportunities to become familiar with GLP and pre-clinical drug development programs - Regulatory compliance leading to IND application - Strategies for translation to Phase I study design